Laboratory Efficacy of Enrofloxacin for the Control ofAeromonas salmonicidaInfection in Rainbow Trout
Paul R. Bowser, Gregory A. Wooster, Hui‐Min Hsu
Abstract
Paul R. Bowser, Gregory A. Wooster, Hui‐Min Hsu
Abstract
Efficacy of enrofloxacin (Baytril®: Bayer Co.) was evaluated in the laboratory for control of Aeromonas salmonicida infection in rainbow trout Oncorhynchus mykiss. Minimuminhibitory-concentration studies of enrofloxacin used against several A. salmonicida isolates indicated efficacy at concentrations below 0.125 μg/mL. In laboratory studies in which rainbow trout were challenged with A. salmonicida, a reduction in percent mortality was observed among fish receiving enrofloxacin (in feed) at rates of 1.25–2.5 mg/kg fish daily for 10 d when compared with mortality of nonmedicated controls.
OpenAlex reports 15 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Efficacy of enrofloxacin (Baytril®: Bayer Co.) was evaluated in the laboratory for control of Aeromonas salmonicida infection in rainbow trout Oncorhynchus mykiss. Minimuminhibitory-concentration studies of enrofloxacin used against several A. salmonicida isolates indicated efficacy at concentrations below 0.125 μg/mL. In laboratory studies in which rainbow trout were challenged with A. salmonicida, a reduction in percent mortality was observed among fish receiving enrofloxacin (in feed) at rates of 1.25–2.5 mg/kg fish daily for 10 d when compared with mortality of nonmedicated controls.
Key concepts: Aeromonas salmonicida, Enrofloxacin, Rainbow trout, Biology, Fishery, Fish <Actinopterygii>, Veterinary medicine, Microbiology